Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia

Saved in:
Bibliographic Details
Published inLeukemia Vol. 31; no. 6; pp. 1453 - 1457
Main Authors Kobayashi, M, Chen, S, Bai, Y, Yao, C, Gao, R, Sun, X-J, Mu, C, Twiggs, T A, Yu, Z-H, Boswell, H S, Yoder, M C, Kapur, R, Mulloy, J C, Zhang, Z-Y, Liu, Y
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2017
Nature Publishing Group
Subjects
13/100
13/106
13/31
13/89
38/39
631/67/71
64/60
692/699/1541/1990/283/1897
82/80
96/44
Acute myelocytic leukemia
Acute myeloid leukemia
AML1 protein
Animals
Biomarkers
Cancer
Cancer Research
Care and treatment
Cell Line, Tumor
Core Binding Factor Alpha 2 Subunit - physiology
Critical Care Medicine
Development and progression
Genetic aspects
Health aspects
Hematology
Humans
Intensive
Internal Medicine
letter-to-the-editor
Letters to the editor
Leukemia
Leukemia, Myeloid, Acute - enzymology
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - pathology
Lymphoma
Medical prognosis
Medicine
Medicine & Public Health
Mice
Oncogene Proteins, Fusion - physiology
Oncology
Pediatrics
Phosphatase
Phosphatases
Population-based studies
Protein Tyrosine Phosphatases - genetics
Protein Tyrosine Phosphatases - metabolism
RUNX1 Translocation Partner 1 Protein - physiology
Socioeconomic factors
Survival Rate
Teenagers
Transcription factors
Young adults
United States > US
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2017.67